Significantly, the pronounced correlation exhibited between TRIP6, and glycolysis-related genes, and angiogenesis-related genes, and immune cell infiltration and immune checkpoint genes suggests that it may serve as a potential target for tumor immunotherapy. This evidence concerns the gene TRIP6 and neoplasm.